Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP
1:24
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP
1:24
|
Dr. Fertrin on the FDA Approval of Avatrombopag in ITP
0:49
|
Investigating the Use of Fostamatinib in ITP
9:47
|
Fostamatinib and efgartigimod: novel agents in the treatment of ITP
1:54
|
Potential Role of Syk Inhibitors in ITP
3:09
|
Fostamatinib as Second-Line ITP Therapy
10:12
|
What is the place for new treatments in ITP - Dr Drew Provan
19:35
|
ITP: Second-Line Therapy
2:26
|
FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More
9:43
|
ITP Treatment Selection Criteria and Treatment Goals
6:59
|
Raymond Wong | ECTH2018 | Eltrombopag Treatment Immune Thrombocytopenia
11:05
|
Immune Thrombocytopenia - 6 June 2020
2:10:11
|
ITP: When to Switch to Second-Line Therapy
3:36
|
ASH Highlights: Efgartigimod Safe and Effective in Treating Immune Thrombocytopenia (ITP)
2:55
|
Dr.Gobind Rai Garg discusses the topic - Fostamatinib
2:18
|
TAVALISSE CLINICAL CORNER (9/20/18)
15:39
|
The association between ITP and multiple myeloma
3:55
|
What is new in ITP? Prof. David Kuter
20:03
|
Cheat Codes #14: International Legends of Sickle Cell: Professor Clarisse Lobo & Dr. Kleber Fertrin
32:05
|
Splenectomy Versus Other Therapy in ITP
7:20
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
